
In a new job - December 1, 2016
New chief adviser for AZ’s genomics initiative
Professor David Goldstein will join AstraZeneca’s in the consultative role of Chief Adviser, Genomics to lead its integrated genomics initiative, which was announced in April. This 10-year initiative will focus on the discovery of new targets and biomarkers linked to molecular mechanisms of disease across AstraZeneca’s main therapy areas. Professor Goldstein will continue in his full-time […]

Drug Development Pharma - April 22, 2016
AZ launches integrated genomics approach
AstraZeneca and its global biologics research and development arm, MedImmune, has announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. The initiative involves for example a new collaboration with the Institute for Molecular Medicine in Finland. The initiative includes new collaborations with Human Longevity, US, the Wellcome […]